ORKA vs. HAL
ORKA (Oruka Therapeutics, Inc) and HAL (Halliburton Company) are both stocks. ORKA operates in Biotechnology (Healthcare), while HAL operates in Oil & Gas Equipment & Services (Energy). Over the past 10 years, ORKA returned -12.31%/yr vs -0.72%/yr for HAL. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
ORKA vs. HAL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ORKA achieves a 218.41% return, which is significantly higher than HAL's 15.16% return. Over the past 10 years, ORKA has underperformed HAL with an annualized return of -12.31%, while HAL has yielded a comparatively higher -0.72% annualized return.
ORKA
- 1D
- -1.38%
- 1M
- 13.26%
- 6M
- 181.95%
- YTD
- 218.41%
- 1Y
- 609.63%
- 3Y*
- 93.94%
- 5Y*
- 36.46%
- 10Y*
- -12.31%
- ALL TIME*
- -28.21%
HAL
- 1D
- 1.93%
- 1M
- -2.15%
- 6M
- -2.91%
- YTD
- 15.16%
- 1Y
- 52.77%
- 3Y*
- -4.21%
- 5Y*
- 11.39%
- 10Y*
- -0.72%
- ALL TIME*
- 5.26%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $496.27M | $402.82M | $436.82M | |
| $77.59M | $103.90M | $107.56M |
ORKA vs. HAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ORKA Oruka Therapeutics, Inc | 218.41% | 56.32% | 76.73% | -28.27% | 10.23% | -46.38% | -29.77% | -4.88% | -75.30% | -52.63% |
HAL Halliburton Company | 15.16% | 7.02% | -23.19% | -6.47% | 74.45% | 21.99% | -21.23% | -4.90% | -44.63% | -8.18% |
Correlation
The correlation between ORKA and HAL is -0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.03 |
Correlation (3Y) Balances recent behavior with more history. | 0.07 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.05 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.10 |
Correlation (All Time) Calculated using the full available price history since Aug 8, 1997 | 0.11 |
The correlation between ORKA and HAL shifts across timeframes, from -0.03 (1 year) to 0.11 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ORKA:
$3.61B
HAL:
$26.94B
ORKA:
-$2.27
HAL:
$1.90
ORKA:
11.01
HAL:
2.45
ORKA:
$0.00
HAL:
$22.37B
ORKA:
-$71.00K
HAL:
$3.58B
ORKA:
-$125.61M
HAL:
$3.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ORKA vs. HAL — Risk / Return Rank
ORKA
HAL
ORKA vs. HAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oruka Therapeutics, Inc (ORKA) and Halliburton Company (HAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ORKA | HAL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +6.55 | ||
| Sortino ratioReturn per unit of downside risk | +3.73 | ||
| Omega ratioGain probability vs. loss probability | 1.68 | 1.23 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 22.00 | 1.75 | +20.25 |
| Martin ratioReturn relative to average drawdown | 71.65 | 5.65 | +66.01 |
Loading charts...
Drawdowns
ORKA vs. HAL - Drawdown Comparison
The maximum ORKA drawdown since its inception was -100.00%, which is greater than HAL's maximum drawdown of -92.99%. Use the drawdown chart below to compare losses from any high point for ORKA and HAL.
Loading charts...
Drawdown Indicators
| ORKA | HAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -92.99% | -7.01% |
Max Drawdown (1Y)Largest decline over 1 year | -27.99% | -27.12% | -0.87% |
Max Drawdown (3Y)Largest decline over 3 years | -77.76% | -54.01% | -23.75% |
Max Drawdown (5Y)Largest decline over 5 years | -77.76% | -54.01% | -23.75% |
Max Drawdown (10Y)Largest decline over 10 years | -98.10% | -91.45% | -6.65% |
Current DrawdownCurrent decline from peak | -100.00% | -45.34% | -54.66% |
Average DrawdownAverage peak-to-trough decline | -93.90% | -39.13% | -54.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.58% | 8.49% | +0.09% |
Volatility
ORKA vs. HAL - Volatility Comparison
Oruka Therapeutics, Inc (ORKA) has a higher volatility of 20.74% compared to Halliburton Company (HAL) at 10.00%. This indicates that ORKA's price experiences larger fluctuations and is considered to be riskier than HAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ORKA | HAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.74% | 10.00% | +10.74% |
Volatility (6M)Calculated over the trailing 6-month period | 53.50% | 23.49% | +30.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.13% | 35.71% | +42.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.55% | 39.87% | +32.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 152.67% | 45.96% | +106.71% |
Dividends
ORKA vs. HAL - Dividend Comparison
ORKA has not paid dividends to shareholders, while HAL's dividend yield for the trailing twelve months is around 2.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HAL Halliburton Company | 2.11% | 2.41% | 2.50% | 1.77% | 1.22% | 0.79% | 1.67% | 2.94% | 2.71% | 1.47% | 1.33% | 2.12% |
ORKA Oruka Therapeutics, Inc | 0.00% | 0.00% | 99.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ORKA vs. HAL - Financials Comparison
This section allows you to compare key financial metrics between Oruka Therapeutics, Inc and Halliburton Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ORKA and HAL have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ORKA has higher volatility (20.74%) compared to HAL (10.00%). In terms of maximum drawdown, ORKA dropped -100.00% vs HAL's -92.99%.
ORKA currently has the higher Sharpe Ratio (7.88 vs 1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ORKA and HAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer